Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland

Heikkilä, Reeta; Mäntyselkä, Pekka; Hartikainen-Herranen, Kaisa; Ahonen, Riitta

doi:10.1016/j.healthpol.2006.10.006

Cited by 112 publications

(180 citation statements)

References 7 publications

Supporting

Mentioning

155

Contrasting

Unclassified

Order By: Relevance

“…However, there are concerns with the effectiveness and tolerability of generics compared with originator drugs [3,7,24,[31][32][33][34][35][36][37], with some originator companies questioning the quality of generics as part of their marketing strategies to reduce the erosion of sales which follow patent loss [38]. Whilst these concerns typically only apply to a minority of situations [34,36,39], as demonstrated for instance by 'dispense as written' prescriptions only accounting for 2.7% of prescriptions written by physicians in the US [30], failure by health authorities, physicians and pharmacists to adequately address these concerns will mean reduced savings in reality [3-5, 17, 40].…”

Section: Review Articlementioning

confidence: 99%

Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach

Godman

Abuelkhair

Vitry³

et al. 2012

GaBI J

107

View full text Add to dashboard Cite

Section: Review Articlementioning

confidence: 99%

Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach

Godman

Abuelkhair

Vitry³

et al. 2012

GaBI J

107

View full text Add to dashboard Cite

“…The implementation of generic drugs and GS can be influenced by physicians' poor understanding of the basic principles and legislation governing GS [14]. General practitioners (GPs) are far from rejecting generic drugs but they are concerned with risks associated with GS and generic drugs.…”

Section: Introductionmentioning

confidence: 99%

“…GPs negative attitudes towards GS can be a result of the pressure from the pharmaceutical companies or concerns in the quality and safety of generic drugs due to e.g. their previous negative experience [13,14,17]. According to Slovenian GPs, the prescription of generic drugs could be enhanced by better information by the independent academic institutions or further clinical testing of generic drugs [17].…”

Section: Introductionmentioning

confidence: 99%

Opinions of Czech general practitioners on generic drugs and substitution

et al. 2014

View full text Add to dashboard Cite

AbstractThe aim of the study was to map and analyze general practitioners` opinions of, attitudes towards and experiences with generic drugs and generic substitution (GS) in the Czech Republic. General practitioners (GPs) who took part in the annual and regional professional conferences of the Society of General Practice in the period from November 2008 until March 2009 were asked to complete the 28-item questionnaire concerning the issue of generic drugs and GS. Questions were organized in 5 sections aimed at assessing the attitude towards GS, understanding the legislation and opinions on statements related to GS. All data were analyzed using descriptive statistics and correlations were tested by selected parametric and non-parametric tests. Total of 263 completed questionnaires were returned (mean age of 52.2 years (SD=13.7), 177 (67.3%) females and 248 (94.3%) GPs having a practice specialization). 99 (37.6%) respondents have considered generic drugs to be bioequivalent to the respective brand name drugs. 121 (46.0%) respondents believed that generic drugs are of lower quality than brand name drugs. None of respondent showed acquaintance with all the legal rules for GS. Awareness of the legislation and attitude towards GS correlated with the age (p<0.001). In conclusion, distrust among GPs in generic drugs derives from poor knowledge and personal experiences.

show abstract

“…This will help to ensure that adequate measures are undertaken towards the goals of stabilizing the generic medicine policies. [3,33,34] During the last few decades, cardiology drugs have experienced an active growth in both numbers and Figure 6. Graphic distribution of satisfaction with fixed-dose combinations.…”

Section: Resultsmentioning

confidence: 99%

Generics and fixed-dose combinations in cardiology: satisfaction analysis of pharmacists and cardiologists

Petrova

Doneva

Mitkova

et al. 2015

Biotechnology & Biotechnological Equipment

View full text Add to dashboard Cite

The purpose of the study was to investigate doctors' and pharmacists' satisfaction with generic medicines and fixed-dose combinations in cardiology by applying the principles of the tetra-class analysis. The questionnaire was distributed among physicians and pharmacists to evaluate their satisfaction with important medicines' characteristics by classifying them in tetra-class groups. The principles of correspondence analysis were used as statistical methodology. The opinion of both cardiologists and pharmacists coincided in 8 out of the 28 elements of all generic medicines' and fixed-dose combinations' characteristics of satisfaction which were included in the questionnaire. The positive evaluation was more distinctive for doctors, whereas pharmacists were found to be slightly more negatively predisposed, which means that they have a higher risk of being dissatisfied. The tetra-class analysis was found to be suitable for the evaluation of satisfaction with generic medicines and fixed-dose combinations in cardiology. It allowed classification of their characteristics, based on their importance for pharmacists and physicians. The results showed that the opinions of doctors and pharmacists differed. Doctors were more satisfied with generic medicines, whereas the satisfaction with fixed-dose combinations was high in both groups of health care specialists.

show abstract

Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland

Cited by 112 publications

References 7 publications

Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach

Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach

Opinions of Czech general practitioners on generic drugs and substitution

Generics and fixed-dose combinations in cardiology: satisfaction analysis of pharmacists and cardiologists

Contact Info

Product

Resources

About